Management of Pleural Effusions

Diagnostic Considerations

The American Thoracic Society recommends thoracentesis as the first-line procedure for diagnosing the etiology of undiagnosed pleural effusions, particularly when malignancy is suspected 1, 2
Ultrasound-guided thoracentesis significantly reduces the risk of pneumothorax (1.0% vs 8.9%) compared to non-guided procedures 3
For diagnostic purposes, 50 mL of fluid is typically adequate for cytologic evaluation, with no increased yield from larger volumes 1
When the first pleural fluid cytology is non-diagnostic, a second specimen yields a diagnosis in approximately 25-28% of cases 2

The American College of Chest Physicians recommends symptomatic relief of dyspnea in patients with pleural effusions using thoracentesis 4, 5
Initial management of malignant pleural effusions to assess symptom improvement should be done using thoracentesis 3, 6
Palliative management in patients with limited life expectancy and poor performance status can be achieved with thoracentesis 5, 7

Caution should be exercised when removing more than 1.5 L of pleural fluid on a single occasion to prevent re-expansion pulmonary edema 5, 4
Small-bore catheters (10-14 F) should be the initial choice for effusion drainage and pleurodesis 5
Indwelling pleural catheters (IPCs) are indicated for recurrent malignant effusions with trapped lung 3, 8

Recurrent symptomatic pleural effusions requiring pleurodesis should be managed with chest tube placement 5, 3
Chemical pleurodesis for prevention of fluid reaccumulation has success rates >60% 5
Indwelling pleural catheters (IPCs) are indicated for long-term outpatient management of recurrent effusions 5, 8

For patients with very limited life expectancy, repeated therapeutic thoracentesis may be appropriate 5, 7
For patients with heart failure-related effusions, medical management should be tried first, with pleural procedures only if refractory 8
Ultrasound guidance should be used for all pleural procedures to reduce complications 3, 1

The American Thoracic Society recommends determining if the patient is symptomatic (dyspnea, chest pain, cough) as this guides management decisions 9
For asymptomatic patients with moderate pleural effusions, observation is recommended without immediate intervention, as suggested by the British Thoracic Society 10, 9

The British Thoracic Society suggests that for a 316 ml effusion, complete drainage is feasible in a single procedure as it is well below the recommended limit of 1.5 liters per session 10
Caution should be exercised when removing larger volumes (>1.5 L) to prevent re-expansion pulmonary edema, according to the British Thoracic Society 10

If symptoms resolve after thoracentesis and do not recur quickly, observation may be appropriate, as recommended by the American College of Chest Physicians and the British Thoracic Society 10, 9
For recurrent symptomatic effusions (especially if malignant), consider more definitive management, such as chemical pleurodesis via chest tube with sclerosant (success rate >60%), as suggested by the British Thoracic Society 10, 11

For malignant pleural effusions, recurrence rate at 1 month after aspiration alone approaches 100%, necessitating consideration of definitive procedures, according to the British Thoracic Society 10, 11

Avoid intercostal tube drainage without pleurodesis as it has a high recurrence rate, as recommended by the British Thoracic Society and the American College of Chest Physicians 10, 12
Do not attempt pleurodesis without confirming complete lung expansion after fluid removal, as suggested by the American Thoracic Society and the British Thoracic Society 13, 11